Publications

Filters (1)
September 13, 2024

Anti-tumor effect of Debio 0432, a potent and selective USP1 inhibitor, in combination with PARP inhibitors

Read more
April 10, 2024

Identification of Debio 0432 as a potent and selective USP1 Inhibitor for Cancer Therapy

Read more